Firecrest blazes trail for protocol-specific training and site visits

By Gareth Macdonald

- Last updated on GMT

Ireland-based Firecrest Clinical says focusing on trial specific training and visits for principal investigators can speed recruitment, cut protocol deviations and produce cleaner data.

Recently appointed CEO Alan Horgan told Outsourcing-pharma that, as the clinical trials sector evolves “investigators are struggling to come to terms with the complexity of trials and the technology they are being asked to use​.”

Such issues, Horgan continued, coupled with the increasing number of multicentre and multinational trials, call for a new approach to site management that was the key motivation for the development of what he believes is the firm’s unique offering.

Essentially what Firecrest does is deliver protocol specific training to the investigator site staff, enabling the sponsor or the CRO to monitor and track the training of the site staff, reducing the time it takes to undertake initiation visits.”

These training programmes are developed by Firecrest’s in-house team based on the specific study protocol and issued to the investigator sites in around six weeks, which is a quicker turnaround than the current site initiation approach according to Horgan.

The other part of the offering is a protocol-specific visit guide that, Horgan claimed, enables investigators to determine precisely what they need to do at each site on a patient by patient basis in as little as two to three minutes.

Horgan explains the benefits of Firecrest's combined training and visits approach in the audio quote below..

Market demand

Despite officially “launching” at the DIA annual meeting in Washington DC in June, Firecrest already claims it works with seven of the top ten pharmaceutical companies around the world.

However, Horgan believes that recognition that making trials easier for principal investigators can have a dramatic impact on a sites efficacy, coupled with ever-present cost pressures, will increase demand for Firecrest’s solution.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars